Last updated: 2026-09-16 10:32:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
QIAGEN N.V. (QGEN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $42,50, with a market capitalisation of $8,65B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $32,53 to $57,82. This page covers its latest market performance, valuation, price trends and company information.
$8,65B | |
$43,10 | |
$62,56 | |
$11,85 | |
$42,48 | |
-- | |
2,82M | |
-- | |
$57,82 | |
$32,53 | |
-- | |
-- |
QIAGEN N.V. (QGEN) is trading at $42,50 in pre-market trading as of 2026-09-16 09:32:00, up 0,04% ($0,02) from the previous close of $42,48
Pre-market trading shows how investors are pricing QGEN before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, QIAGEN N.V. (QGEN) moved from $43,47 to $42,50, representing a decline of 2,24% ($0,97).
The stock traded between $41,74 and $43,66 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 1,53 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 39,4%
QGEN is currently trading at $42,50, placing it 39,4% of the way from its 52-week low of $32,53 to its 52-week high of $57,82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
| Employees | 5500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of QIAGEN N.V. (QGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.